Search results
Author(s):
Sunil Kapur
,
Moussa Mansour
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than three million Americans.1 The management of AF revolves around the alleviation of symptoms related to an accelerated and irregular ventricular response, and the prevention of cardioembolism, notably stroke. In patients with AF, there is a fivefold increased incidence of embolic stroke.2 The prevention of systemic…
View more
Author(s):
Thorsten Lewalter
,
Giuseppe Boriani
Added:
3 years ago
The monitoring of atrial fibrillation (AF) can be performed using a great variety of strategies and tools. Strategies range from monitoring only symptomatic AF (e.g., post-catheter ablation with or without surface electrocardiogram [ECG] documentation) to continuously monitoring heart rhythm using implantable pacemakers, implantable cardioverter defibrillators (ICDs) or subcutaneous implantable…
View more
Author(s):
Dipen Shah
Added:
6 years ago
This interview with Dipen Shah from Geneva University Hospital, Geneva, Switzerland discusses best practice in Atrial Fibrillation Ablation.
Filmed by Radcliffe Cardiology on-site at EHRA 2017.
View more
Author(s):
Stefan Spitzer
Added:
2 years ago
Identify which patient groups are most likely to benefit from Atrial Fibrillation ablation and the optimal time for patient referral in this video with Professor Dr Stefan Spitzer.
Key Learning Objectives:
Which patients are likely to benefit most from ablation
When to refer for ablation
Practical guidance for improving access to ablation for relevant patients
Additional Learning…
View more
Author(s):
George D Katritsis
,
Demosthenes G Katritsis
Added:
3 years ago
Implantable cardiac devices, such as pacemakers, are used to treat a number of heart conditions, especially those related to the electrical conduction system. Cardiac pacemakers are a well-established and effective therapy, and have been in use for more than 50 years.
The first pacemaker was implanted in a patient in October 1958 by Åke Senning in Stockholm, in cooperation with engineer Rune…
View more
Ep 3: Atrial Fibrillation in Congenital Heart Disease
Author(s):
Irene Martín de Miguel
Added:
2 years ago
Podcast Episode
Author(s):
Ahmed M Al-Kaisey
,
William Figgett
,
Joshua Hawson
,
et al
Added:
11 months ago
Author(s):
Pepie Tsolka
Added:
3 years ago
Novel oral anticoagulants (NOACs) represent new options for preventing stroke in patients with atrial fibrillation (AF), and have been approved for use in North America and Europe. They carry a 50 % lower risk of intracranial haemorrhage compared with warfarin, no clear interactions with food, fewer interactions with medications and no need for frequent laboratory monitoring and dose adjustments…
View more
Author(s):
Yoga Waranugraha
,
Ardian Rizal
,
Mohammad Saifur Rohman
,
et al
Added:
1 year ago
Author(s):
Vincent Umbrain
,
Christian Verborgh
,
Gian-Battista Chierchia
,
et al
Added:
3 years ago
The current option for refractory treatment for atrial fibrillation (AF) includes hybrid AF-surgery.1–2 The hybrid approach was originally a combination of mini-invasive surgical epicardial evaluation and ablation, as well as endocardial electrophysiologist (EP) catheter ablation with the intention of creating a lesion set to cure AF.3 In the search for greater efficacy with less patient…
View more